Log in to your Inderes Free account to see all free content on this page.

Apotea

56.50 SEK

-3.42 %

Less than 1K followers

APOTEA

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

-3.42 %

-7.01 %

-38.73 %

-36.08 %

-42.88 %

-32.42 %

-

-

-32.74 %

Apotea operates in the e-commerce sector and operates an online pharmacy. The company sells and delivers a wide range of prescription and non-prescription medicines, skin and hair care products, as well as makeup and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and is headquartered in Stockholm.

Market cap

5.95B SEK

Turnover

49.28M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

29.4.

2026

Interim report Q1'26

26.5.

2026

General meeting '26

27.5.

2026

Annual dividend

All

Webcasts

Press releases

ShowingAll content types

Apotea, Webcast, Q4'25

Webcast2/4/2026, 8:30 AM

Apotea, Webcast, Q4'25

Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) Year-end report 2025: Weak profitability in the fourth quarter

Regulatory press release1/28/2026, 1:39 PM

Apotea has recruited Joanna Hummel to accelerate the company’s growth initiatives

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release1/20/2026, 5:16 PM

Update regarding the fourth quarter of 2025

Press release12/18/2025, 10:30 AM

Invitation to Apotea’s presentation of the year-end report 2025

Apotea, Webcast, Q3'25

Webcast11/6/2025, 8:30 AM

Apotea, Webcast, Q3'25

Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) Interim report Q3 2025: Successful production launch in Varberg and continued good profitability

Press release10/3/2025, 8:00 AM

Invitation to Apotea’s Q3 2025 webcast

Regulatory press release8/22/2025, 6:55 AM

Apotea: Employee representatives on the Board of Directors

Apotea, Webcast, Q2'25

Webcast7/18/2025, 7:30 AM

Apotea, Webcast, Q2'25

Regulatory press release7/18/2025, 5:30 AM

Apotea AB (publ) Interim report Q2 2025: Strengthened profitability and increased demand for prescription products

Press release6/18/2025, 6:30 AM

Invitation to Apotea's Q2 2025 webcast

Regulatory press release5/28/2025, 9:45 AM

Bulletin from Apotea AB's (publ) Annual General Meeting on May 28, 2025

Apotea, Webcast with teleconference, Q1'25

Webcast5/8/2025, 7:30 AM

Apotea, Webcast with teleconference, Q1'25

Regulatory press release5/8/2025, 5:30 AM

Apotea AB (publ) Interim report Q1 2025: Improved profitability and solid growth in times of uncertainty

Regulatory press release4/29/2025, 5:30 AM

Apotea publishes annual and sustainability report for the financial year 2024

Regulatory press release4/23/2025, 7:30 AM

Notice to Annual General Meeting in Apotea AB (publ)

Regulatory press release4/11/2025, 11:00 AM

The Nomination Committee's proposal for the Board of Directors of Apotea AB (publ)

Press release4/4/2025, 6:30 AM

Invitation to Apotea's Q1 2025 webcast

Regulatory press release4/3/2025, 7:30 PM

Apotea Sverige AB cooperates with the Swedish Competition Authority (Konkurrensverket) in an investigation on paid search advertising contacts

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.